Related Experiment Videos

[Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)]

La Nouvelle Presse Medicale
|December 9, 1978
PubMed

Insights

Epstein-Barr virus (EBV) causes infectious mononucleosis, with antibodies appearing at different stages. Viral capsid antigen (VCA) antibodies are early indicators, while nuclear antigen (EBNA) antibodies appear later.

Area of Science:

  • Virology
  • Immunology

Context:

  • Infectious mononucleosis presents with diverse clinical and hematological signs.
  • Epstein-Barr virus (EBV) is a primary etiological agent, but its serological markers require detailed characterization.

Purpose:

  • To investigate the temporal dynamics of Epstein-Barr virus (EBV) antibody responses in patients with infectious mononucleosis.
  • To correlate specific antibody profiles with disease progression and identify co-infections.

Summary:

  • Thirty-seven patients with infectious mononucleosis were studied for EBV serology.
  • Antibodies to viral capsid antigen (VCA) and early antigen (EA) were detected early, while EBNA antibodies appeared late.
  • VCA-specific IgM antibodies were transient, and heterophile antibodies were less common, especially in older adults.
  • Co-infections with rubella and adenovirus were noted, alongside cytomegalovirus infections in some patients without acute EBV markers.

Impact:

  • This study clarifies the diagnostic utility of different EBV antibody types in infectious mononucleosis.
  • Understanding antibody kinetics aids in accurate diagnosis and management of EBV infections.
  • Highlights the importance of considering co-infections in the differential diagnosis.

Related Concept Videos